These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2680241

  • 1. Epoetin: human recombinant erythropoietin.
    Flaharty KK, Grimm AM, Vlasses PH.
    Clin Pharm; 1989 Nov; 8(11):769-82. PubMed ID: 2680241
    [Abstract] [Full Text] [Related]

  • 2. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G, Italian Society of Nephrology.
    G Ital Nefrol; 2003 Nov; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human erythropoietin.
    Jones EH.
    Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S20-3. PubMed ID: 2690606
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A, Salifu MO, Lunde NM, Bansal V, Fishbane S, Dougherty FC, Beyer U, Ba16285 Study Investigators.
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin 1991--an overview.
    Eschbach JW.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):3-9. PubMed ID: 1928076
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 10. Review of patients' responses to epoetin alfa therapy.
    Krantz SB.
    Pharmacotherapy; 1990 Jul; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
    Bieber E.
    J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
    [Abstract] [Full Text] [Related]

  • 12. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
    Van Wyck DB.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082
    [Abstract] [Full Text] [Related]

  • 13. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 14. Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
    Mercuriali F.
    Semin Hematol; 1996 Apr 15; 33(2 Suppl 2):18-20; discussion 21. PubMed ID: 8723576
    [Abstract] [Full Text] [Related]

  • 15. Pathophysiology and treatment of the anemia of renal failure.
    Johnson CA, Chester MI.
    Clin Pharm; 1988 Feb 15; 7(2):117-22. PubMed ID: 3280218
    [Abstract] [Full Text] [Related]

  • 16. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 15; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 17. Adverse effects of therapy for the correction of anemia in hemodialysis patients.
    Watson AJ.
    Semin Nephrol; 1989 Mar 15; 9(1 Suppl 1):30-4. PubMed ID: 2648519
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A.
    Pediatr Hematol Oncol; 2008 Sep 15; 25(6):509-21. PubMed ID: 18728970
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
    Stovall TG.
    J Reprod Med; 2001 May 15; 46(5 Suppl):531-8. PubMed ID: 11396387
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar 15; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.